These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25192989)

  • 1. The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state.
    Marques CN; Morozov A; Planzos P; Zelaya HM
    Appl Environ Microbiol; 2014 Nov; 80(22):6976-91. PubMed ID: 25192989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Staphylococcus aureus persister cells with the host when in a persister state and following awakening.
    Mina EG; Marques CN
    Sci Rep; 2016 Aug; 6():31342. PubMed ID: 27506163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persister cells.
    Lewis K
    Annu Rev Microbiol; 2010; 64():357-72. PubMed ID: 20528688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Granulocyte Macrophage Colony-Stimulating Factor Enhances Antibiotic Susceptibility of Pseudomonas aeruginosa Persister Cells.
    Choudhary GS; Yao X; Wang J; Peng B; Bader RA; Ren D
    Sci Rep; 2015 Nov; 5():17315. PubMed ID: 26616387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis.
    Mulcahy LR; Burns JL; Lory S; Lewis K
    J Bacteriol; 2010 Dec; 192(23):6191-9. PubMed ID: 20935098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persister Escherichia coli Cells Have a Lower Intracellular pH than Susceptible Cells but Maintain Their pH in Response to Antibiotic Treatment.
    Goode O; Smith A; Zarkan A; Cama J; Invergo BM; Belgami D; Caño-Muñiz S; Metz J; O'Neill P; Jeffries A; Norville IH; David J; Summers D; Pagliara S
    mBio; 2021 Aug; 12(4):e0090921. PubMed ID: 34281389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
    Cameron DR; Shan Y; Zalis EA; Isabella V; Lewis K
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29941425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a potent indigoid persister antimicrobial by screening dormant cells.
    Song S; Gong T; Yamasaki R; Kim JS; Wood TK
    Biotechnol Bioeng; 2019 Sep; 116(9):2263-2274. PubMed ID: 31161664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one.
    Pan J; Bahar AA; Syed H; Ren D
    PLoS One; 2012; 7(9):e45778. PubMed ID: 23029239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-crosslinker cisplatin eradicates bacterial persister cells.
    Chowdhury N; Wood TL; Martínez-Vázquez M; García-Contreras R; Wood TK
    Biotechnol Bioeng; 2016 Sep; 113(9):1984-92. PubMed ID: 26914280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit
    Jin X; Zhou J; Richey G; Wang M; Hong SMC; Hong SH
    J Microbiol Biotechnol; 2021 Jan; 31(1):130-136. PubMed ID: 33046677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stochastic Variation in Expression of the Tricarboxylic Acid Cycle Produces Persister Cells.
    Zalis EA; Nuxoll AS; Manuse S; Clair G; Radlinski LC; Conlon BP; Adkins J; Lewis K
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules.
    Möker N; Dean CR; Tao J
    J Bacteriol; 2010 Apr; 192(7):1946-55. PubMed ID: 20097861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.
    Hansen S; Lewis K; Vulić M
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2718-26. PubMed ID: 18519731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
    Xu Y; Cui P; Zhang Y; Zhang W
    Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides.
    Chen X; Zhang M; Zhou C; Kallenbach NR; Ren D
    Appl Environ Microbiol; 2011 Jul; 77(14):4878-85. PubMed ID: 21622798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of Biofilms with the Fatty Acid Signaling Molecule cis-2-Decenoic Acid.
    Marques CN; Davies DG; Sauer K
    Pharmaceuticals (Basel); 2015 Nov; 8(4):816-35. PubMed ID: 26610524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Freezing Enables Aminoglycosides To Eradicate Bacterial Persisters via Enhancing Mechanosensitive Channel MscL-Mediated Antibiotic Uptake.
    Zhao Y; Lv B; Sun F; Liu J; Wang Y; Gao Y; Qi F; Chang Z; Fu X
    mBio; 2020 Feb; 11(1):. PubMed ID: 32047133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.